TRAF-Type Zinc Finger Domain Containing 1 (TRAFD1) Antibody

Product Graph
169€ (20 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
TRAF-Type Zinc Finger Domain Containing 1 (TRAFD1) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx305779
tested applications
ELISA

Description

TRAFD1 Antibody is a Rabbit Polyclonal against TRAFD1.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
TRAF-Type Zinc Finger Domain Containing 1 (TRAFD1)
Host
Rabbit
Reactivity
Human
Recommended Dilution
Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Isotype
IgG
Purity
> 95%
Purification
Purified by Protein G.
Size 1
20 µg
Size 2
50 µg
Size 3
100 µg
Size 4
200 µg
Size 5
1 mg
Form
Liquid
Tested Applications
ELISA
Buffer
0.01 M PBS, pH 7.4, 0.03% Proclin-300 and 50% Glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
O14545
Gene ID
10906
NCBI Accession
NP_001137378.1, NM_001143906.1
OMIM
613197
Background
Antibody anti-TRAFD1
Status
RUO

Descripción

Related Products

abx016014

TRAF-Type Zinc Finger Domain Containing 1 (TRAFD1) Antibody

The innate immune system confers host defense against viral and microbial infection, and TRAFD1 is a negative feedback regulator that controls excessive immune responses ; ;.

Ver Producto
abx016015

TRAF-Type Zinc Finger Domain Containing 1 (TRAFD1) Antibody

The innate immune system confers host defense against viral and microbial infection, and TRAFD1 is a negative feedback regulator that controls excessive immune responses ; ;.

Ver Producto
abx029363

TRAF-Type Zinc Finger Domain Containing 1 (TRAFD1) Antibody

The innate immune system confers host defense against viral and microbial infection, and TRAFD1 is a negative feedback regulator that controls excessive immune responses (Sanada et al., 2008 [PubMed 18849341]).

Ver Producto